CN111658580A - 含有多种肽与植物提取物的生发和/或白发转黑发精华液及其制备方法 - Google Patents
含有多种肽与植物提取物的生发和/或白发转黑发精华液及其制备方法 Download PDFInfo
- Publication number
- CN111658580A CN111658580A CN202010577272.3A CN202010577272A CN111658580A CN 111658580 A CN111658580 A CN 111658580A CN 202010577272 A CN202010577272 A CN 202010577272A CN 111658580 A CN111658580 A CN 111658580A
- Authority
- CN
- China
- Prior art keywords
- hair
- tripeptide
- volatile oil
- platycladi
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 95
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 30
- 230000003779 hair growth Effects 0.000 title claims abstract description 25
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 25
- 239000000419 plant extract Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title description 13
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims abstract description 54
- 239000000284 extract Substances 0.000 claims abstract description 43
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 27
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims abstract description 26
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims abstract description 26
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims abstract description 26
- 229940036350 bisabolol Drugs 0.000 claims abstract description 26
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims abstract description 26
- RRJOMESUBQAYOA-BZSNNMDCSA-N (2S)-2-[[(2S)-2-[[2-[[(2S)-2-acetamido-6-aminohexanoyl]amino]acetyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-6-aminohexanamide Chemical compound NCCCC[C@H](NC(=O)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(N)=O)CC1=CN=CN1 RRJOMESUBQAYOA-BZSNNMDCSA-N 0.000 claims abstract description 18
- 229910052802 copper Inorganic materials 0.000 claims abstract description 11
- 239000010949 copper Substances 0.000 claims abstract description 11
- 239000000686 essence Substances 0.000 claims description 47
- 239000000341 volatile oil Substances 0.000 claims description 46
- 239000000203 mixture Substances 0.000 claims description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 29
- 239000000843 powder Substances 0.000 claims description 25
- 238000002156 mixing Methods 0.000 claims description 22
- 239000000047 product Substances 0.000 claims description 21
- 241001474374 Blennius Species 0.000 claims description 16
- 239000008367 deionised water Substances 0.000 claims description 16
- 229910021641 deionized water Inorganic materials 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000006210 lotion Substances 0.000 claims description 8
- 238000005325 percolation Methods 0.000 claims description 8
- 238000010298 pulverizing process Methods 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000002453 shampoo Substances 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 229940127554 medical product Drugs 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 230000001256 tonic effect Effects 0.000 claims 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 abstract description 36
- 230000000694 effects Effects 0.000 abstract description 35
- 210000004761 scalp Anatomy 0.000 abstract description 27
- 231100000360 alopecia Toxicity 0.000 abstract description 24
- 210000003780 hair follicle Anatomy 0.000 abstract description 23
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 208000003251 Pruritus Diseases 0.000 abstract description 6
- 230000007803 itching Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 230000035755 proliferation Effects 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 210000000130 stem cell Anatomy 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 108010076876 Keratins Proteins 0.000 abstract description 2
- 240000002924 Platycladus orientalis Species 0.000 abstract description 2
- 230000004069 differentiation Effects 0.000 abstract description 2
- 210000001732 sebaceous gland Anatomy 0.000 abstract description 2
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 208000024963 hair loss Diseases 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 230000003676 hair loss Effects 0.000 description 11
- 229920001184 polypeptide Polymers 0.000 description 7
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- FECNOIODIVNEKI-UHFFFAOYSA-N 2-[(2-aminobenzoyl)amino]benzoic acid Chemical class NC1=CC=CC=C1C(=O)NC1=CC=CC=C1C(O)=O FECNOIODIVNEKI-UHFFFAOYSA-N 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- LHXDLQBQYFFVNW-UHFFFAOYSA-N Fenchone Chemical compound C1CC2(C)C(=O)C(C)(C)C1C2 LHXDLQBQYFFVNW-UHFFFAOYSA-N 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002768 hair cell Anatomy 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- LHXDLQBQYFFVNW-XCBNKYQSSA-N (+)-Fenchone Natural products C1C[C@]2(C)C(=O)C(C)(C)[C@H]1C2 LHXDLQBQYFFVNW-XCBNKYQSSA-N 0.000 description 1
- 229930007105 (-)-alpha-thujone Natural products 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010015943 Eye inflammation Diseases 0.000 description 1
- 102000002151 Microfilament Proteins Human genes 0.000 description 1
- 108010040897 Microfilament Proteins Proteins 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- -1 etc. Substances 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930006735 fenchone Natural products 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000000442 hair follicle cell Anatomy 0.000 description 1
- 230000009583 hair follicle growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- WTDHMFBJQJSTMH-UHFFFAOYSA-N hinokiflavone Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(OC=3C=CC(=CC=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)=C(O)C=C2O1 WTDHMFBJQJSTMH-UHFFFAOYSA-N 0.000 description 1
- HLFVFEBKCLAGBY-UHFFFAOYSA-N hinokiflavone Natural products Oc1ccc(cc1)C2=COc3cc(O)c(Oc4ccc(cc4)C5=CC(=O)c6c(O)cc(O)cc6O5)c(O)c3C2=O HLFVFEBKCLAGBY-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003752 improving hair Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 108010028309 kalinin Proteins 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000001024 permanent hair color Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000007873 thujene derivatives Chemical class 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- USMNOWBWPHYOEA-MRTMQBJTSA-N α-thujone Chemical compound O=C([C@@H]1C)C[C@@]2(C(C)C)[C@@H]1C2 USMNOWBWPHYOEA-MRTMQBJTSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明公开一种含有多种肽与植物提取物的生发和/或白发转黑发精华液,由三肽‑1,三肽‑1铜,乙酰基四肽‑3,侧柏叶提取物,大叶海藻提取物,以及红没药醇制备而成。本发明通过复配植物中药成分和小分子肽类成分,改善头皮血液循环、抗氧化、抗自由基、修复毛囊组织、激活角蛋白基因,促进毛发生长,维持头皮营养健康的环境。有效发挥活血、抗炎、抑菌、抑制皮脂腺过度分泌、促进毛囊干细胞增殖分化的作用,达到止痒、控油、健发、防脱发的效果,使白发从根发黑,不仅能够快速将白发转黑发,并且能有效消除脱发、枯发症状。成分天然安全,温和无刺激性,起效快,不含任何潜在危害。
Description
技术领域
本发明涉及日化用品技术领域,更具体的涉及一种含有多种肽与植物提取物的生发和/或白发转黑发精华液及其制备方法。
背景技术
头发是人体组织的一部份,是由细胞所组成的有机体。头发细胞是从毛囊内分裂,以倍数增加,新生头发就会从发囊推向头皮皮肤表面。毛发的生长周期分为生长期(约2-6年)、休止期(约2-3周)和退化期(约2-3月),日脱发量100根以内在医学上视为正常脱发量,当日脱发量大于100根则被认为有脱发困扰。每个头发毛囊在一年内便会生出新头发。如果头发缺乏必须的活性蛋白质(毛发细胞生长蛋白),头发便会在每次更新替换后逐渐萎缩,渐渐由粗变幼,由幼长变幼短,再变成幼而细,萎缩直至肉眼难见的白绒毛,形成日常所见的秃头症状。
脱发的病因很多,例如因外源性的细菌感染和继发的炎症浸润对毛囊干细胞的破坏而脱发;头皮微丝血管不活跃导致发根营养的缺失而脱发;生物体内二氢睾酮的异常分泌导致毛发生长周期变短,毛囊微小化甚至萎缩而脱发;烫染对头皮的危害;家族遗传病因;体内免疫力下降等。其中最常见的脱发类型为脂溢性脱发和神经性脱发。现有技术中用于治疗脱发的制剂主要成分为西药、中草药有效物或活性多肽类产品。
临床用于治疗脱发的西药如马前列肢、米诺地尔,马前列肢的过量使用会造成视神经损伤,可能导致视力下降甚至失明,此外还可能造成视网膜肿胀和眼睛发炎等不良后果。米诺地尔的副作用也会导致头皮发炎以及面部毛发增加。
多肽类物质和中草药组合物具有防脱健发的作用,但是各有利弊。中草药组合物的工艺简单,制作成本低,具有辅助增效作用,但是防脱发效果不佳,且见效缓慢;多肽类物质合成困难、储存条件要求高,制造成本高,且往往只具有防脱发效果,而无辅助增效作用,虽然活性多肽类产品针对靶点专一,起效快,但却没有中药提取物的多方位的辅助增效作用。
此外,随着工作生活节奏的加快,脑力劳动的过度负担,除了容易导致脱发外,少年/中年白发的现象越来越普遍,越来越严重。
作为主要使用的永久性染发剂,其染发原理是采用氨水使头发膨胀和软化,毛鳞片打开从而使染料中间体和偶合剂更好的扩散渗透到皮质层,染料中间体和偶合剂发生氧化反应、偶合和缩合反应形成较大的染料分子,染料大分子被封闭在头发纤维内,从而使头发染上颜色。虽然一时解决了白发问题,但没有从根本改善,新的头发长出来后依然是白色的。
已知市场上有一些含有中草药的黑发产品,但大多停留在概念上的炒作,效果不确切,甚至使用激素而给患者带来很大的副作用。
因此,亟需一种能够使抑制脱发、促进生发和白发转黑发的安全产品。
发明内容
本发明的目的在于克服现有技术存在的缺陷,提供一种含有多种肽与植物提取物的生发和/或白发转黑发精华液。
为了实现上述目的,本发明采用的技术方案如下:
一种含有多种肽与植物提取物的生发和/或白发转黑发精华液,由如下质量百分比的原料组成:
三肽-1:0.01-0.1%;
三肽-1铜:0.01-0.05%;
乙酰基四肽-3:2-5%;
侧柏叶提取物:50-70%
大叶海藻提取物:5-20%
红没药醇:0.2-1%;
乙二醇:1-5%;
剩余为去离子水。
优选地,所述侧柏叶提取物由侧柏叶挥发油组分和侧柏叶水溶性组分按1:50-200的体积比组成。
本发明还提供所述净化液的制备方法,包括如下步骤:
(a1)取各原料,将红没药醇和侧柏叶挥发油组分与三肽-1粉末以及三肽-1铜粉末,混合均匀,静置至少1h,使红没药醇、侧柏叶挥发油部分被三肽-1粉末和三肽-1铜粉末吸收,再加入乙二醇,搅拌均匀后加入乙酰基四肽-3粉末,焖过夜,得到混合物A;
(a2)将大叶海藻提取物分散到去离子水中,在搅拌条件下升温到35-50℃,然后再加入侧柏叶水溶性组分,得到混合物B;
(a3)将混合物A与混合物B放入均质机中,均质至少20min,即得。
优选地,所述侧柏叶挥发油组分和侧柏叶水溶性组分通过如下方法制成:
(b1)取侧柏叶,粉碎,置于挥发油提取罐中,加水浸泡1-2h后回流提取2-3次,提取液离心,静置,分层后取上层提取液,即为侧柏叶挥发油组分,密封保存,下层提取液备用;
(b2)取步骤(b1)的残渣,放入渗漉筒中,用乙醇渗漉3-5h,收集渗漉液;
(b3)合并步骤(b1)的下层提取液与步骤(b2)的渗漉液,离心,静置,取上层澄清液;
(b4)将上层澄清液在60-65℃下浓缩至醇含量不超过30%,且相对密度为1.05-1.10,即得侧柏叶水溶性组分。
优选地,可用乙醇或异丙醇替代乙二醇。
本发明的精华液可应用在日化用品或医用产品的领域。
所述日化用品包括但不限于精华液、香波、乳液、霜剂、喷雾剂、凝胶、洗液、软膏剂中的任意一种。
本发明由于采用了上述技术方案,具有以下有益效果:
1、本发明精华液中的植物提取物与多种小分子肽物质具有协调增效的效果,在促进毛发生长方面,明显优于纯中药配方;与纯多肽配方相比,效果更佳,且在止痒、控油等其他辅助功效方面明显优于纯多肽配方。三肽-1能增加细胞外基质如胶原蛋白IV和层粘连蛋白5合成,延缓毛囊衰老,改善毛囊结构,有利头发固着在真皮毛囊内,防止脱发;激活组织修复基因表达,有利于皮肤结构重建和修复;促进细胞增殖和分化,刺激头发生长。三肽-1铜能促进毛乳头细胞增殖和头发生长因子表达,对抗毛囊老化、防止脱发,作为强有力的组织保护和消炎剂,保护受伤组织免受氧化进一步损害,具有促进头发生长、伤口愈合等作用。乙酰基四肽-3可以迅速修复毛囊细胞,刺激眉毛和头发自然增长,能有效减少因为老化而导致的毛发脱落现象,令眉毛和头发更加浓密、自然、柔顺和紧致。侧柏叶提取物中含有黄酮类和斛皮素,对修复头皮炎症,改善头皮生态环境,固发生发有很好的疗效,常用于血热脱发或须发早白等。红没药醇具有抗炎和抑菌活性,其渗透作用是常用渗透剂的几十倍,帮助多种肽物质和植物提取液渗透头皮毛囊,增强毛囊的修复作用。
2、侧柏叶中含挥发油0.26%,油中主要成分为α-侧柏酮、侧柏烯、小茴香酮等,其它尚含黄酮类成分,如香橙素、槲皮素、杨梅树皮素、扁柏双黄酮等。为了保留侧柏叶中的挥发油成分,本发明的精华液在制备时,先采用小分子肽粉末吸收挥发油成分,使挥发油成分被充分锁住。在提取侧柏叶挥发组分后,再将侧柏叶残渣进行渗漉,充分提取了侧柏叶中的有效活性成分,极大限度利用原材料。
3、本发明的精华液除了具有生发、黑发的作用外,三肽-1铜和三肽-1可以促使皮肤上皮组织再生,恢复肌肤年轻,减少粗细皱纹与疤痕,改善肌肤弹性,使角质细胞和纤维姆细胞增生,更可以让皮下组织增厚,使肌肤不再脆弱敏感,增加皮肤弹性与韧度,也让保养品在脸上能被最大化的吸收利用。大叶海藻提取物是天然的保湿柔润剂,能促进细胞再生,具有强化皮肤新陈代谢的功能,有独特的去角质的作用,能使皮肤更新,防止皱纹产生。因此,本品也可用在皮肤修复、皮肤保养品的应用上。
综上所述,本发明通过复配植物中药成分和小分子肽类成分,改善头皮血液循环、抗氧化、抗自由基、修复毛囊组织、激活角蛋白基因,促进毛发生长,维持头皮营养健康的环境。有效发挥活血、抗炎、抑菌、抑制皮脂腺过度分泌、促进毛囊干细胞增殖分化的作用,达到止痒、控油、健发、防脱发的效果,让头皮、头发和毛囊得到充足的营养,激活头发毛囊中酪氨酸酶活性,促进黑色素合成,从而使白发从根发黑,不仅能够快速将白发转黑发,并且能有效消除脱发、枯发症状。成分天然安全,温和无刺激性,起效快,对脱发和白发的各种症状有很好的改善效果,不含任何潜在危害。
具体实施方式
为使本发明的目的、技术方案及优点更加清楚明白,以下举出优选实施例,对本发明进一步详细说明。然而,需要说明的是,说明书中列出的许多细节仅仅是为了使读者对本发明的一个或多个方面有一个透彻的理解,即便没有这些特定的细节也可以实现本发明的这些方面。
实施例1
一种含有多种肽与植物提取物的生发和/或白发转黑发精华液,由如下质量百分比的原料组成:
三肽-1:0.01%,三肽-1铜:0.05%,乙酰基四肽-3:2%,侧柏叶提取物:50%,大叶海藻提取物:20%,红没药醇:0.2%,乙二醇:5%,剩余为去离子水,所述侧柏叶提取物由侧柏叶挥发油组分和侧柏叶水溶性组分按1:50的体积比组成。
其制备方法如下:
(b1)取侧柏叶,粉碎,置于挥发油提取罐中,加水浸泡1h后在回流提取2次,将提取液在2000rpm转速下离心2min,静置3h,分层后取上层提取液,即为侧柏叶挥发油组分,密封保存,下层提取液备用;
(b2)取步骤(b1)的残渣,放入渗漉筒中,用乙醇渗漉5h,收集渗漉液;
(b3)合并步骤(b1)的下层提取液与步骤(b2)的渗漉液,在1500rpm的转速下离心3min,静置2h,取上层澄清液;
(b4)将上层澄清液在60℃下浓缩至醇含量为30%,且相对密度为1.05,即得侧柏叶水溶性组分;
(a1)取其余各原料,将红没药醇和侧柏叶挥发油组分与三肽-1粉末以及三肽-1铜粉末,混合均匀,静置1h,使红没药醇、侧柏叶挥发油部分被三肽-1粉末和三肽-1铜粉末吸收,再加入乙二醇,搅拌均匀后加入乙酰基四肽-3粉末,焖过夜,得到混合物A;
(a2)将大叶海藻提取物分散到去离子水中,在100rpm的搅拌条件下升温到50℃,然后再加入侧柏叶水溶性组分,得到混合物B;
(a3)将混合物A与混合物B放入均质机中,在3500rpm的转速下均质30min,即得。
当上述精华液用于头皮、头发和毛囊时,将精华液稀释10倍后再使用。也可将该精华液作为洗发香波的添加剂来使用,添加量为洗发香波质量的1%。
实施例2
一种含有多种肽与植物提取物的生发和/或白发转黑发精华液,由如下质量百分比的原料组成:
三肽-1:0.03%,三肽-1铜:0.04%,乙酰基四肽-3:2.6%,侧柏叶提取物:54%,大叶海藻提取物:17%,红没药醇:0.3%,乙二醇:4.2%,剩余为去离子水,所述侧柏叶提取物由侧柏叶挥发油组分和侧柏叶水溶性组分按1:80的体积比组成。
其制备方法如下:
(b1)取侧柏叶,粉碎,置于挥发油提取罐中,加水浸泡1.2h后在回流提取3次,将提取液在1800rpm转速下离心4min,静置2h,分层后取上层提取液,即为侧柏叶挥发油组分,密封保存,下层提取液备用;
(b2)取步骤(b1)的残渣,放入渗漉筒中,用乙醇渗漉3h,收集渗漉液;
(b3)合并步骤(b1)的下层提取液与步骤(b2)的渗漉液,在2000rpm的转速下离心5min,静置1h,取上层澄清液;
(b4)将上层澄清液在61℃下浓缩至醇含量为28%,且相对密度为1.06,即得侧柏叶水溶性组分;
(a1)取其余各原料,将红没药醇和侧柏叶挥发油组分与三肽-1粉末以及三肽-1铜粉末,混合均匀,静置2h,使红没药醇、侧柏叶挥发油部分被三肽-1粉末和三肽-1铜粉末吸收,再加入乙二醇,搅拌均匀后加入乙酰基四肽-3粉末,焖过夜,得到混合物A;
(a2)将大叶海藻提取物分散到去离子水中,在80rpm的搅拌条件下升温到45℃,然后再加入侧柏叶水溶性组分,得到混合物B;
(a3)将混合物A与混合物B放入均质机中,在3800rpm的转速下均质25min,即得。
当上述精华液用于头皮、头发和毛囊时,将精华液稀释30倍后再使用。也可将该精华液作为乳液的添加剂来使用,添加量为乳液质量的5%。
实施例3
一种含有多种肽与植物提取物的生发和/或白发转黑发精华液,由如下质量百分比的原料组成:
三肽-1:0.05%,三肽-1铜:0.03%,乙酰基四肽-3:3.2%,侧柏叶提取物:59%,大叶海藻提取物:14%,红没药醇:0.5%,乙醇:3.4%,剩余为去离子水,所述侧柏叶提取物由侧柏叶挥发油组分和侧柏叶水溶性组分按1:110的体积比组成。
其制备方法如下:
(b1)取侧柏叶,粉碎,置于挥发油提取罐中,加水浸泡1.4h后在回流提取3次,将提取液在2100rpm转速下离心1.5min,静置1.5h,分层后取上层提取液,即为侧柏叶挥发油组分,密封保存,下层提取液备用;
(b2)取步骤(b1)的残渣,放入渗漉筒中,用乙醇渗漉3.4h,收集渗漉液;
(b3)合并步骤(b1)的下层提取液与步骤(b2)的渗漉液,在1200rpm的转速下离心7min,静置1.5h,取上层澄清液;
(b4)将上层澄清液在62℃下浓缩至醇含量为27%,且相对密度为1.07,即得侧柏叶水溶性组分;
(a1)取其余各原料,将红没药醇和侧柏叶挥发油组分与三肽-1粉末以及三肽-1铜粉末,混合均匀,静置2.5h,使红没药醇、侧柏叶挥发油部分被三肽-1粉末和三肽-1铜粉末吸收,再加入乙醇,搅拌均匀后加入乙酰基四肽-3粉末,焖过夜,得到混合物A;
(a2)将大叶海藻提取物分散到去离子水中,在50rpm的搅拌条件下升温到40℃,然后再加入侧柏叶水溶性组分,得到混合物B;
(a3)将混合物A与混合物B放入均质机中,在4000rpm的转速下均质20min,即得。
当上述精华液用于头皮、头发和毛囊时,将精华液稀释50倍后再使用。也可将该精华液作为护肤的霜剂的添加剂来使用,添加量为霜剂质量的8%。
实施例4
一种含有多种肽与植物提取物的生发和/或白发转黑发精华液,由如下质量百分比的原料组成:
三肽-1:0.07%,三肽-1铜:0.02%,乙酰基四肽-3:3.8%,侧柏叶提取物:63%,大叶海藻提取物:11%,红没药醇:0.7%,乙醇:2.6%,剩余为去离子水,所述侧柏叶提取物由侧柏叶挥发油组分和侧柏叶水溶性组分按1:140的体积比组成。
其制备方法如下:
(b1)取侧柏叶,粉碎,置于挥发油提取罐中,加水浸泡1.6h后在回流提取2次,将提取液在1700rpm转速下离心8min,静置2h,分层后取上层提取液,即为侧柏叶挥发油组分,密封保存,下层提取液备用;
(b2)取步骤(b1)的残渣,放入渗漉筒中,用乙醇渗漉3.8h,收集渗漉液;
(b3)合并步骤(b1)的下层提取液与步骤(b2)的渗漉液,在1600rpm的转速下离心5min,静置2h,取上层澄清液;
(b4)将上层澄清液在63℃下浓缩至醇含量为25%,且相对密度为1.08,即得侧柏叶水溶性组分;
(a1)取其余各原料,将红没药醇和侧柏叶挥发油组分与三肽-1粉末以及三肽-1铜粉末,混合均匀,静置1.5h,使红没药醇、侧柏叶挥发油部分被三肽-1粉末和三肽-1铜粉末吸收,再加入乙醇,搅拌均匀后加入乙酰基四肽-3粉末,焖过夜,得到混合物A;
(a2)将大叶海藻提取物分散到去离子水中,在70rpm的搅拌条件下升温到35℃,然后再加入侧柏叶水溶性组分,得到混合物B;
(a3)将混合物A与混合物B放入均质机中,在4200rpm的转速下均质23min,即得。
当上述精华液用于头皮、头发和毛囊时,将精华液稀释70倍后再使用。也可将该精华液作为护肤的喷雾剂的添加剂来使用,添加量为喷雾剂质量的10%。
实施例5
一种含有多种肽与植物提取物的生发和/或白发转黑发精华液,由如下质量百分比的原料组成:
三肽-1:0.08%,三肽-1铜:0.01%,乙酰基四肽-3:4.5%,侧柏叶提取物:68%,大叶海藻提取物:8%,红没药醇:0.8%,异丙醇:1.8%,剩余为去离子水,所述侧柏叶提取物由侧柏叶挥发油组分和侧柏叶水溶性组分按1:170的体积比组成。
其制备方法如下:
(b1)取侧柏叶,粉碎,置于挥发油提取罐中,加水浸泡1.8h后在回流提取2次,将提取液在2000rpm转速下离心4min,静置1h,分层后取上层提取液,即为侧柏叶挥发油组分,密封保存,下层提取液备用;
(b2)取步骤(b1)的残渣,放入渗漉筒中,用乙醇渗漉4.2h,收集渗漉液;
(b3)合并步骤(b1)的下层提取液与步骤(b2)的渗漉液,在1000rpm的转速下离心10min,静置3h,取上层澄清液;
(b4)将上层澄清液在64℃下浓缩至醇含量为20%,且相对密度为1.09,即得侧柏叶水溶性组分;
(a1)取其余各原料,将红没药醇和侧柏叶挥发油组分与三肽-1粉末以及三肽-1铜粉末,混合均匀,静置1.8h,使红没药醇、侧柏叶挥发油部分被三肽-1粉末和三肽-1铜粉末吸收,再加入异丙醇,搅拌均匀后加入乙酰基四肽-3粉末,焖过夜,得到混合物A;
(a2)将大叶海藻提取物分散到去离子水中,在45rpm的搅拌条件下升温到38℃,然后再加入侧柏叶水溶性组分,得到混合物B;
(a3)将混合物A与混合物B放入均质机中,在2500rpm的转速下均质30min,即得。
当上述精华液直接用于头皮、头发和毛囊时,将精华液稀释80倍后再使用。也可将该精华液用作护肤的凝胶剂的添加剂,添加量为凝胶剂质量的7%。
实施例6
一种含有多种肽与植物提取物的生发和/或白发转黑发精华液,由如下质量百分比的原料组成:
三肽-1:0.1%,三肽-1铜:0.01%,乙酰基四肽-3:5%,侧柏叶提取物:70%,大叶海藻提取物:5%,红没药醇:1%,异丙醇:1%,剩余为去离子水,所述侧柏叶提取物由侧柏叶挥发油组分和侧柏叶水溶性组分按1:200的体积比组成。
其制备方法如下:
(b1)取侧柏叶,粉碎,置于挥发油提取罐中,加水浸泡2h后在回流提取3次,将提取液在1500rpm转速下离心6min,静置2h,分层后取上层提取液,即为侧柏叶挥发油组分,密封保存,下层提取液备用;
(b2)取步骤(b1)的残渣,放入渗漉筒中,用乙醇渗漉4.5h,收集渗漉液;
(b3)合并步骤(b1)的下层提取液与步骤(b2)的渗漉液,在1500rpm的转速下离心5min,静置3h,取上层澄清液;
(b4)将上层澄清液在65℃下浓缩至醇含量为15%,且相对密度为1.10,即得侧柏叶水溶性组分;
(a1)取其余各原料,将红没药醇和侧柏叶挥发油组分与三肽-1粉末以及三肽-1铜粉末,混合均匀,静置2h,使红没药醇、侧柏叶挥发油部分被三肽-1粉末和三肽-1铜粉末吸收,再加入异丙醇,搅拌均匀后加入乙酰基四肽-3粉末,焖过夜,得到混合物A;
(a2)将大叶海藻提取物分散到去离子水中,在75rpm的搅拌条件下升温到42℃,然后再加入侧柏叶水溶性组分,得到混合物B;
(a3)将混合物A与混合物B放入均质机中,在3000rpm的转速下均质35min,即得。
当上述精华液直接用于头皮、头发和毛囊时,将精华液稀释100倍后再使用。也可将该精华液用作护肤的洗液的添加剂,添加量为洗液质量的15%。
生发效果评价
选取有脱发困扰志愿者70名,年龄在23-55岁,随机分为试验组和对照组,每组35人,两组在脱发情况、年龄、性别上无明显差异。试验组使用本发明实施例1的精华液,对照组使用目前市场销售较好的防脱生发液样品(简称:市售样品)。
试验方法:每次洗完头发以后,头发七成干时,将精华液/市售样品涂抹在头皮上,按摩2-5分钟至吸收,连续使用90天;其中第1-7天连续使用,往后每2-3天使用一次。
疗效标准:
(1)显效:无明显脱发,有大量新毛发生成,头发清爽不油腻,头皮不瘙痒。
(2)有效:脱发得到控制,有少量新毛发生成,头发油腻程度和头皮瘙痒程度改善。
(3)无效:治疗前后无变化。
结果见表1。
组别 | 显效 | 有效 | 无效 | 总有效率/% |
试验组 | 21 | 11 | 3 | 91.4 |
对照组 | 6 | 23 | 6 | 82.9 |
表1生发效果
如表1所示,本发明的精华液在促进头皮毛囊生长,改善头发密度、脱发数量及头发油腻程度、头皮瘙痒程度上的有效率均高于对照组。说明本发明的精华液有较好的的控油、防脱、生发的效果。
黑发效果评价
选取73名有白发的志愿者进行治疗,年龄在20-57岁,使用本发明实施例2的精华液。每次洗完头发以后,头发七成干时,将精华液涂抹在头皮上,按摩2-5分钟至吸收,连续使用90天;其中第1-7天连续使用,往后每2-3天使用一次。
疗效标准:
(1)痊愈:白发全部变黑。
(2)显效:白发变黑数量>80%。
(3)有效:白发变黑数量>30%。
(4)无效:治疗前后无变化或白发变黑数量≤30%。
黑发效果见表2。
使用天数 | 痊愈 | 显效 | 有效 | 无效 | 总有效率/% |
7天 | 2 | 9 | 12 | 50 | 31.5 |
21天 | 6 | 14 | 23 | 30 | 58.9 |
42天 | 29 | 18 | 17 | 9 | 87.7 |
63天 | 38 | 18 | 12 | 5 | 93.2 |
90天 | 51 | 11 | 10 | 1 | 98.6 |
表2黑发效果
如表2所示,使用本发明的精华液3个月后,经头皮检测仪观测白发根部,几乎全部志愿者的白发状况都有所改善,更有69.7%的志愿白发完全变黑,黑发效果非常明显。
在上述进行脱发和黑发试验的志愿者中,有部分志愿者是具有脱发兼白发的情况,在使用本发明的精华液后,脱发和黑发的状况均得到改善,头发变多变浓密,原本白发长出的根部大部分呈黑色或深灰色。
Claims (7)
1.一种含有多种肽与植物提取物的生发和/或白发转黑发精华液,其特征在于,由如下质量百分比的原料组成:
三肽-1:0.01-0.1%;
三肽-1铜:0.01-0.05%;
乙酰基四肽-3:2-5%;
侧柏叶提取物:50-70%
大叶海藻提取物:5-20%
红没药醇:0.2-1%;
乙二醇:1-5%;
剩余为去离子水。
2.根据权利要求1所述的含有多种肽与植物提取物的生发和/或白发转黑发精华液,其特征在于,所述侧柏叶提取物由侧柏叶挥发油组分和侧柏叶水溶性组分按1:50-200的体积比组成。
3.根据权利要求2所述的含有多种肽与植物提取物的生发和/或白发转黑发精华液,其特征在于,其制备方法包括如下步骤:
(a1)取各原料,将红没药醇和侧柏叶挥发油组分与三肽-1粉末以及三肽-1铜粉末,混合均匀,静置至少1h,使红没药醇、侧柏叶挥发油部分被三肽-1粉末和三肽-1铜粉末吸收,再加入乙二醇,搅拌均匀后加入乙酰基四肽-3粉末,焖过夜,得到混合物A;
(a2)将大叶海藻提取物分散到去离子水中,在搅拌条件下升温到35-50℃,然后再加入侧柏叶水溶性组分,得到混合物B;
(a3)将混合物A与混合物B放入均质机中,均质至少20min,即得。
4.根据权利要求2所述的含有多种肽与植物提取物的生发和/或白发转黑发精华液,其特征在于,所述侧柏叶挥发油组分和侧柏叶水溶性组分通过如下方法制成:
(b1)取侧柏叶,粉碎,置于挥发油提取罐中,加水浸泡1-2h后回流提取2-3次,提取液离心,静置,分层后取上层提取液,即为侧柏叶挥发油组分,密封保存,下层提取液备用;
(b2)取步骤(b1)的残渣,放入渗漉筒中,用乙醇渗漉3-5h,收集渗漉液;
(b3)合并步骤(b1)的下层提取液与步骤(b2)的渗漉液,离心,静置,取上层澄清液;
(b4)将上层澄清液在60-65℃下浓缩至醇含量不超过30%,且相对密度为1.05-1.10,即得侧柏叶水溶性组分。
5.根据权利要求1所述的含有多种肽与植物提取物的生发和/或白发转黑发精华液,其特征在于,可用乙醇或异丙醇替代乙二醇。
6.根据权利要求1-5任一项所述的含有多种肽与植物提取物的生发和/或白发转黑发精华液,其特征在于,在日化用品或医用产品上的用途。
7.根据权利要求6所述的含有多种肽与植物提取物的生发和/或白发转黑发精华液,其特征在于,所述日化用品为精华液、香波、乳液、霜剂、喷雾剂、凝胶、洗液、软膏剂中的任意一种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010577272.3A CN111658580A (zh) | 2020-06-23 | 2020-06-23 | 含有多种肽与植物提取物的生发和/或白发转黑发精华液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010577272.3A CN111658580A (zh) | 2020-06-23 | 2020-06-23 | 含有多种肽与植物提取物的生发和/或白发转黑发精华液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111658580A true CN111658580A (zh) | 2020-09-15 |
Family
ID=72389437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010577272.3A Pending CN111658580A (zh) | 2020-06-23 | 2020-06-23 | 含有多种肽与植物提取物的生发和/或白发转黑发精华液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111658580A (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112107527A (zh) * | 2020-09-22 | 2020-12-22 | 广东嘉丹婷日用品有限公司 | 一种防脱精华液及其制备方法 |
CN112569159A (zh) * | 2021-01-04 | 2021-03-30 | 广州瑞誉化工科技有限公司 | 一种防脱护发组合物、护发精华液及其制备方法 |
CN113750023A (zh) * | 2021-09-23 | 2021-12-07 | 广州市番禺成业化妆品厂 | 一种促进头发生长的头皮营养组合物 |
CN114191339A (zh) * | 2021-12-30 | 2022-03-18 | 中国科学院过程工程研究所 | 一种用于头皮和面部皮肤的护理精华液及其制备方法和应用 |
CN114191365A (zh) * | 2021-12-31 | 2022-03-18 | 盈馨堂(武汉)商贸有限公司 | 一种防脱生发精华液及其制备方法 |
CN114224754A (zh) * | 2021-12-28 | 2022-03-25 | 广西和桂集团有限公司 | 一种含植物提取物调节头皮油脂分泌、亮发、顺发的组合物及含有该组合物的洗发剂 |
CN114288221A (zh) * | 2022-01-10 | 2022-04-08 | 广西和桂集团有限公司 | 一种有生发作用的含多肽和植物提取液的精华液的制备方法及其应用 |
CN115317397A (zh) * | 2022-09-23 | 2022-11-11 | 广西和桂集团有限公司 | 一种含多肽洗发水及制备方法 |
CN115475111A (zh) * | 2022-09-23 | 2022-12-16 | 上海纳米技术及应用国家工程研究中心有限公司 | 一种搭配微针使用的生发原液及其制备方法和应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101732208A (zh) * | 2010-01-20 | 2010-06-16 | 云南省药物研究所 | 一种中药组合物在制备控油洗发剂中的应用 |
CN102614102A (zh) * | 2012-04-27 | 2012-08-01 | 昆明远方生物制品有限公司 | 一种去头屑药物组合物及其制备方法 |
CN106823454A (zh) * | 2017-03-22 | 2017-06-13 | 广州国草夏方生物科技有限公司 | 一种侧柏叶中挥发油与黄酮的连续选择性提取方法 |
CN107362085A (zh) * | 2017-08-03 | 2017-11-21 | 天津中医药大学 | 一种以侧柏叶为主的中药生发乌发洗发水 |
CN108992385A (zh) * | 2018-08-27 | 2018-12-14 | 天津市康婷生物工程有限公司 | 一种毛囊修复育发精华液 |
CN109498537A (zh) * | 2018-12-26 | 2019-03-22 | 广州蜜妆生物科技有限公司 | 一种防脱生发液及其制备方法 |
CN111110600A (zh) * | 2019-12-31 | 2020-05-08 | 泉后(深圳)投资发展有限公司 | 一种头皮净化促生发组合物及其乳液 |
CN111202756A (zh) * | 2018-11-21 | 2020-05-29 | 南京泽朗医药科技有限公司 | 一种侧柏叶乙醇提取物的制备方法 |
-
2020
- 2020-06-23 CN CN202010577272.3A patent/CN111658580A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101732208A (zh) * | 2010-01-20 | 2010-06-16 | 云南省药物研究所 | 一种中药组合物在制备控油洗发剂中的应用 |
CN102614102A (zh) * | 2012-04-27 | 2012-08-01 | 昆明远方生物制品有限公司 | 一种去头屑药物组合物及其制备方法 |
CN106823454A (zh) * | 2017-03-22 | 2017-06-13 | 广州国草夏方生物科技有限公司 | 一种侧柏叶中挥发油与黄酮的连续选择性提取方法 |
CN107362085A (zh) * | 2017-08-03 | 2017-11-21 | 天津中医药大学 | 一种以侧柏叶为主的中药生发乌发洗发水 |
CN108992385A (zh) * | 2018-08-27 | 2018-12-14 | 天津市康婷生物工程有限公司 | 一种毛囊修复育发精华液 |
CN111202756A (zh) * | 2018-11-21 | 2020-05-29 | 南京泽朗医药科技有限公司 | 一种侧柏叶乙醇提取物的制备方法 |
CN109498537A (zh) * | 2018-12-26 | 2019-03-22 | 广州蜜妆生物科技有限公司 | 一种防脱生发液及其制备方法 |
CN111110600A (zh) * | 2019-12-31 | 2020-05-08 | 泉后(深圳)投资发展有限公司 | 一种头皮净化促生发组合物及其乳液 |
Non-Patent Citations (2)
Title |
---|
广西和桂集团有限公司: "源生堂三肽精华液", 《国产非特殊用途化妆品备案信息服务平台,HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=20200523102154WI7QH&NID=20200523102154WI7QH》 * |
董淑炎: "《健美益寿天然食品》", 31 March 1991, 北京:中国旅游出版社 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112107527A (zh) * | 2020-09-22 | 2020-12-22 | 广东嘉丹婷日用品有限公司 | 一种防脱精华液及其制备方法 |
CN112569159A (zh) * | 2021-01-04 | 2021-03-30 | 广州瑞誉化工科技有限公司 | 一种防脱护发组合物、护发精华液及其制备方法 |
CN113750023A (zh) * | 2021-09-23 | 2021-12-07 | 广州市番禺成业化妆品厂 | 一种促进头发生长的头皮营养组合物 |
CN114224754A (zh) * | 2021-12-28 | 2022-03-25 | 广西和桂集团有限公司 | 一种含植物提取物调节头皮油脂分泌、亮发、顺发的组合物及含有该组合物的洗发剂 |
CN114224754B (zh) * | 2021-12-28 | 2023-05-16 | 广西和桂集团有限公司 | 一种含植物提取物调节头皮油脂分泌、亮发、顺发的组合物及含有该组合物的洗发剂 |
CN114191339A (zh) * | 2021-12-30 | 2022-03-18 | 中国科学院过程工程研究所 | 一种用于头皮和面部皮肤的护理精华液及其制备方法和应用 |
CN114191365A (zh) * | 2021-12-31 | 2022-03-18 | 盈馨堂(武汉)商贸有限公司 | 一种防脱生发精华液及其制备方法 |
CN114288221A (zh) * | 2022-01-10 | 2022-04-08 | 广西和桂集团有限公司 | 一种有生发作用的含多肽和植物提取液的精华液的制备方法及其应用 |
CN115317397A (zh) * | 2022-09-23 | 2022-11-11 | 广西和桂集团有限公司 | 一种含多肽洗发水及制备方法 |
CN115475111A (zh) * | 2022-09-23 | 2022-12-16 | 上海纳米技术及应用国家工程研究中心有限公司 | 一种搭配微针使用的生发原液及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111658580A (zh) | 含有多种肽与植物提取物的生发和/或白发转黑发精华液及其制备方法 | |
CN111529417B (zh) | 一种具有抗蓝光功效修护眼霜及其制备方法 | |
CN109953926B (zh) | 五维抗皱、抗衰作用的护肤品及其制备方法 | |
KR20150129492A (ko) | 두피 보호 및 모발 개선 조성물을 함유한 샴푸와 그 제조방법 | |
CN109260116A (zh) | 一种含有植物提取物的至肽肌底液及其生产工艺 | |
CN110721148A (zh) | 一种多方位提拉紧致多肽精华液及其制备方法 | |
CN115300432A (zh) | 一种晒后修护组合物及其制备方法与应用 | |
CN113633599B (zh) | 一种含铁皮石斛提取物的肌底精华液及其制备方法 | |
CN114288221A (zh) | 一种有生发作用的含多肽和植物提取液的精华液的制备方法及其应用 | |
KR102671809B1 (ko) | 자주천인국 및 보리지 혼합 추출물과 아미노산을 유효성분으로 포함하는 콜라겐 생성 촉진용 조성물 | |
CN104825347A (zh) | 一种医用生物美白袪斑敷料及其制备方法 | |
CN114099387A (zh) | 一种玫瑰美白保湿精华乳及其制备方法 | |
CN117357447A (zh) | 一种芍药美白祛斑提取液 | |
CN112370411A (zh) | 一种美白修护精华液及其制备方法 | |
CN112089674A (zh) | 一种鱼子酱肌因修复精华液及其制备方法 | |
CN108888554B (zh) | 具有嫩肤淡斑的干细胞美容乳液及其制备方法 | |
KR101139373B1 (ko) | 미백용 피부 미용 조성물 및 그의 제조방법 및 이를 함유한 마스크 팩 | |
CN108354891B (zh) | 一种舒缓乳霜及其制备方法 | |
KR102403451B1 (ko) | 펩타이드 복합체 및 천연 복합 추출물을 함유하는 다기능성 화장료 조성물 | |
CN112842983B (zh) | 一种用于敏感肌修复的草本乳液及其制备方法 | |
CN108186438A (zh) | 一种含有细胞生长因子的晒后修复凝胶及其制备方法 | |
KR20230152511A (ko) | 피부 트러블 완화 효과가 우수한 피부 재생용 화장료, 이의 제조방법 및 이를 포함하는 화장품 | |
CN1054284C (zh) | 护肤天然原料——新疆雪莲醇提物 | |
CN112957304A (zh) | 一种用于化妆品的植物组合物、混合提取液及制备方法 | |
CN111544335A (zh) | 一种含可溶性胶原和孔雀石提取物的精华及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200915 |